Dr. John R. Mcrae, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
TN license MD013502
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Nashville, TN | 71 |
| Ozempic (semaglutide) Other prescribers in Nashville, TN | 43 |
| Mounjaro (tirzepatide) Other prescribers in Nashville, TN | 28 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Nashville, TN | 26 |
| Novolog Flexpen (insulin aspart) Other prescribers in Nashville, TN | 24 |
| Testosterone Cypionate Other prescribers in Nashville, TN | 22 |
| Jardiance (empagliflozin) Other prescribers in Nashville, TN | 20 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Nashville, TN | 17 |
| Humalog Kwikpen U-100 (insulin lispro) Other prescribers in Nashville, TN | 17 |
| Cinacalcet Hcl Other prescribers in Nashville, TN | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 18 payments worth $411 in total to this clinician.
| Novo Nordisk Inc | $84.79 |
|---|---|
| Cequr Corporation | $69.04 |
| Ascendis Pharma Endocrinology Inc | $46.03 |
| Medtronic, Inc. | $40.02 |
| Tandem Diabetes Care, Inc. | $34.09 |
| Abbott Laboratories | $27.44 |
| Beta Bionics, Inc. | $25.36 |
| AbbVie Inc. | $24.32 |
| Food and Beverage | $411 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.